Css LLC Exelixis, Inc. Call Options Transaction History

Css LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	BUY	$17.44 - $23.16 $436,000 - $579,000	25,000 New	25,000 $520,000
Q1 2018 May 15, 2018	SELL	$22.15 - $31.89 $465,149 - $669,690	-21,000 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$24.23 - $30.93 $169,610 - $216,510	-7,000 Reduced 25.0%	21,000 $638,000
Q3 2017 Nov 14, 2017	BUY	$23.35 - $29.24 $653,800 - $818,720	28,000	28,000 $679,000

503

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.4B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.